408 related articles for article (PubMed ID: 16212991)
1. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
2. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations.
Chi L; Reith ME
J Pharmacol Exp Ther; 2003 Nov; 307(2):729-36. PubMed ID: 12975490
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
4. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
5. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.
Zhen J; Chen N; Reith ME
Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
Boudanova E; Navaroli DM; Melikian HE
Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
Gorentla BK; Vaughan RA
Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.
Yu PL; Wu CI; Lee TS; Pan WH; Wang PS; Wang SW
J Cell Biochem; 2009 Dec; 108(6):1318-24. PubMed ID: 19830701
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
10. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
[TBL] [Abstract][Full Text] [Related]
11. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
12. Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR; Sorkin A
Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
[TBL] [Abstract][Full Text] [Related]
13. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
[TBL] [Abstract][Full Text] [Related]
14. Bupropion increases striatal vesicular monoamine transport.
Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
[TBL] [Abstract][Full Text] [Related]
15. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
16. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
17. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.
Richards TL; Zahniser NR
J Neurochem; 2009 Mar; 108(6):1575-84. PubMed ID: 19183252
[TBL] [Abstract][Full Text] [Related]
18. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
19. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
